Emma K. Grant

ORCID: 0009-0005-5229-9125
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Click Chemistry and Applications
  • Protein Degradation and Inhibitors
  • DNA Repair Mechanisms
  • CRISPR and Genetic Engineering
  • Chemical Synthesis and Analysis
  • Renal and related cancers
  • Animal Genetics and Reproduction
  • Ubiquitin and proteasome pathways
  • Peptidase Inhibition and Analysis
  • Computational Drug Discovery Methods
  • Innovative Microfluidic and Catalytic Techniques Innovation
  • Synthesis and Catalytic Reactions
  • Multiple Myeloma Research and Treatments
  • Digestive system and related health
  • Advanced Breast Cancer Therapies
  • PARP inhibition in cancer therapy
  • Cancer-related Molecular Pathways
  • Nuclear Structure and Function
  • Cancer-related gene regulation
  • RNA modifications and cancer
  • Biomarkers in Disease Mechanisms
  • Spectroscopy Techniques in Biomedical and Chemical Research
  • Protein Kinase Regulation and GTPase Signaling
  • Histone Deacetylase Inhibitors Research
  • Cannabis and Cannabinoid Research

GlaxoSmithKline (United Kingdom)
2019-2024

Indiana University Bloomington
2024

Age UK
2024

University of Strathclyde
2019-2023

AstraZeneca (Brazil)
2022

University of Sheffield
2017-2022

Abstract Micronuclei represent the cellular attempt to compartmentalize DNA maintain genomic integrity threatened by mitotic errors and genotoxic events. Some micronuclei show aberrant nuclear envelopes (NEs) that collapse, generating damaged can promote complex genome alterations. However, ruptured also provide a pool of cytosolic stimulate antitumor immunity, revealing complexity micronuclear impact on tumor progression. The ESCRT-III (Endosomal Sorting Complex Required for Transport-III)...

10.1038/s41389-019-0136-0 article EN cc-by Oncogenesis 2019-04-15

Here, we report a comprehensive profiling of sulfur(VI) fluorides (SVI-Fs) as reactive groups for chemical biology applications. SVI-Fs are functionalities that modify lysine, tyrosine, histidine, and serine sidechains. A panel were studied with respect to hydrolytic stability reactivity nucleophilic amino acid The use covalently carbonic anhydrase II (CAII) range kinases was then investigated. Finally, the SVI-F used in live cell chemoproteomic workflows, identifying novel protein targets...

10.1021/acschembio.2c00633 article EN cc-by ACS Chemical Biology 2023-01-17

Carboxylesterases (CEs) are a class of enzymes that catalyze the hydrolysis esters in variety endogenous and exogenous molecules. CEs play an important role drug metabolism, onset progression disease, can be harnessed for prodrug activation strategies. As such, regulation is clinical pharmaceutical consideration. Here, we report first ratiometric sensor CE activity using Raman spectroscopy based on bisarylbutadiyne scaffold. The was shown to highly sensitive specific detection had low...

10.1021/acs.analchem.2c05708 article EN cc-by Analytical Chemistry 2023-03-16

Microsatellite-unstable (MSI) cancers require WRN helicase to resolve replication stress due expanded DNA (TA)n dinucleotide repeats. is a promising synthetic lethal target for MSI tumors, and inhibitors are in development. In this study, we used CRISPR-Cas9 base editing map residues critical cells, validating the domain as primary drug target. Fragment-based screening led development of potent highly selective covalent inhibitors. These compounds selectively suppressed model growth vitro...

10.1158/2159-8290.cd-24-0052 article EN Cancer Discovery 2024-04-06

Poly(ADP-ribosylation) of proteins following DNA damage is well studied and the use poly(ADP-ribose) polymerase (PARP) inhibitors as therapeutic agents an exciting prospect for treatment many cancers. Poly(ADP-ribose) glycohydrolase (PARG) has endo- exoglycosidase activities which can cleave glycosidic bonds, rapidly reversing action PARP enzymes. Like addition (PAR) by PARP, removal PAR PARG also thought to be required repair strand breaks continued replication at perturbed forks. Here we...

10.1016/j.dnarep.2017.02.010 article EN cc-by DNA repair 2017-02-17

Methods for rapid identification of chemical tools are essential the validation emerging targets and to provide medicinal chemistry starting points development new medicines. Here, we report a screening platform that combines 'direct-to-biology' high-throughput (D2B-HTC) with photoreactive fragments. The enabled synthesis >1000 PhotoAffinity Bits (HTC-PhABits) in 384-well plates 24 h their subsequent as crude reaction products protein target without purification. Screening HTC-PhABit library...

10.1039/d1sc03551g article EN Chemical Science 2021-01-01

Upon DNA binding the poly(ADP-ribose) polymerase family of enzymes (PARPs) add multiple ADP-ribose subunits to themselves and other acceptor proteins. Inhibitors PARPs have become an exciting real prospect for monotherapy as sensitizers ionising radiation (IR). The action are reversed by glycohydrolase (PARG). Until recently studies PARG been limited lack inhibitor. Here, a first in class, specific, cell permeable inhibitor, PDD00017273, is shown radiosensitize. Further, PDD00017273 compared...

10.1016/j.dnarep.2017.11.004 article EN cc-by DNA repair 2017-11-23

Advances in genomic analyses enable the identification of new proteins that are associated with disease. To validate these targets, tool molecules required to demonstrate a ligand can have disease-modifying effect. Currently, as tools reported for only fraction proteome, platforms discovery essential leverage insights from analyses. Fragment screening offers an efficient approach explore chemical space. Presented here is fragment-screening platform, termed PhABits (PhotoAffinity Bits), which...

10.1002/anie.202008361 article EN Angewandte Chemie International Edition 2020-08-03

Abstract The CDK family plays a crucial role in the control of cell cycle. Dysregulation and mutation CDKs has been implicated cancer have investigated extensively as potential therapeutic targets. Selective inhibition specific isoforms is to achieve effect while minimising toxicity. We present group photoaffinity probes designed bind CDKs. site crosslinking optimised probe, well its ability enrich members from lysates, was investigated. In proof concept study, we subsequently developed...

10.1002/anie.201906321 article EN Angewandte Chemie International Edition 2019-09-13

We report a ‘direct-to-biology’ (D2B) approach for optimising covalent acrylamide binders of protein targets and apply this to the identification selective cell-active inhibitor Werner (WRN) helicase. Inhibition WRN helicase activity exhibits synthetic lethal relationship with cancers displaying high microsatellite instability (MSI-H) is being pursued as therapeutic strategy in clinic. Using intact-protein liquid chromatography-mass spectrometry (LC-MS) screening, we identified fragment...

10.26434/chemrxiv-2025-tvdzn preprint EN cc-by-nc-nd 2025-03-06

We present a carboxylate-targeting reactive fragment screening platform using 2-aryl-5-carboxytetrazole (ACT) as the photoreactive functionality. This work will provide simple accessible method to rapidly discover tool molecules interrogate important biological targets.

10.1039/d2md00453d article EN cc-by RSC Medicinal Chemistry 2023-01-01

Reactive fragment (RF) screening has emerged as an efficient method for ligand discovery across the proteome, irrespective of a target’s perceived tractability. To date, however, efficiency subsequent optimisation campaigns largely been low‐throughput, constrained by need synthesis and purification target compounds. We report high‐throughput platform ‘direct‐to‐biology’ (D2B) cysteine‐targeting chloroacetamide RFs, wherein is performed in 384‐well plates allowing direct assessment downstream...

10.1002/anie.202418314 article EN Angewandte Chemie International Edition 2024-12-04

Fragment screening is a popular strategy of generating viable chemical starting points especially for challenging targets. Although fragments provide better coverage space and they have typically higher chance binding, their weak affinity necessitates highly sensitive biophysical assays. Here, we introduce concept that combines evolutionary optimized fragment pharmacophores with the use photoaffinity handle enables high hit rates by LC-MS-based detection. The sensitivity our protocol was...

10.1038/s42004-024-01252-w article EN cc-by Communications Chemistry 2024-07-31

Chemical probes are valuable tools to explore the function of proteins. Incorporation electrophiles into small molecules enables covalent capture protein interactions and provides access powerful technologies including chemoproteomic profiling reactive fragment screening. Current approaches have been largely limited pockets containing cysteine, so establishing strategies target other amino acid residues is essential expanding applicability across proteome. Here, we profiled sulfur(VI)...

10.26434/chemrxiv-2022-j8b8d-v2 preprint EN cc-by-nc 2022-02-16

Chemoresistance poses a great barrier to breast cancer treatment and is thought correlate with increased matrix stiffness. We developed two-dimensional (2D) polyacrylamide (PAA) three-dimensional (3D) alginate in vitro models of tissue stiffness that mimic the normal cancer. then used these compare cell viability response chemotherapeutic treatment. In both 2D 3D we observed growth size was at higher corresponding tumours compared tissue. When measured, specific differential for gemcitabine...

10.1371/journal.pone.0268300 article EN cc-by PLoS ONE 2022-05-26

Abstract Advances in genomic analyses enable the identification of new proteins that are associated with disease. To validate these targets, tool molecules required to demonstrate a ligand can have disease‐modifying effect. Currently, as tools reported for only fraction proteome, platforms discovery essential leverage insights from analyses. Fragment screening offers an efficient approach explore chemical space. Presented here is fragment‐screening platform, termed PhABits (PhotoAffinity...

10.1002/ange.202008361 article EN Angewandte Chemie 2020-08-03

<p>Methods for rapid identification of chemical tools are essential the validation emerging targets and to provide medicinal chemistry starting points development <a>new medicines. Here, we report a screening platform that combines ‘direct-to-biology’ high-throughput (D2B-HTC) with photoreactive covalent fragments. The enabled synthesis >1000 PhotoAffinity Bits (HTC-PhABits) in 384-well plates. Screening HTC-PhABit library </a>carbonic anhydrase I (CAI) afforded 7 hits...

10.26434/chemrxiv.14261780 preprint EN cc-by-nc-nd 2021-03-24

Abstract The CDK family plays a crucial role in the control of cell cycle. Dysregulation and mutation CDKs has been implicated cancer have investigated extensively as potential therapeutic targets. Selective inhibition specific isoforms is to achieve effect while minimising toxicity. We present group photoaffinity probes designed bind CDKs. site crosslinking optimised probe, well its ability enrich members from lysates, was investigated. In proof concept study, we subsequently developed...

10.1002/ange.201906321 article EN Angewandte Chemie 2019-09-13

Target validation remains a challenge in drug discovery, which leads to high attrition rate the discovery process, particularly Phase II clinical trials. Consequently, new approaches enhance target are valuable tools improve process. Here we report combination of site-directed mutagenesis and electrophilic fragments enable rapid identification small molecules that selectively inhibit mutant protein. Using bromodomain- containing protein BRD4 as an example, employed structure-based approach...

10.26434/chemrxiv-2023-8qnvr preprint EN cc-by 2023-07-25

The synthesis and characterisation of fluorosulfate covalent inhibitors the lipid kinase PI4KIIIβ is described. conserved lysine residue located within ATP binding site was targeted, optimised compounds based upon reversible with good activity physicochemical profile showed strong interactions slow onset times for inhibition, resulting in an excellent selectivity target. X-Ray crystallography demonstrated a distal tyrosine could also be targeted using strategy. Combination this knowledge...

10.1039/d3cb00142c article EN cc-by RSC Chemical Biology 2023-01-01

Target validation remains a challenge in drug discovery, which leads to high attrition rate the discovery process, particularly Phase II clinical trials. Consequently, new approaches enhance target are valuable tools improve process. Here, we report combination of site-directed mutagenesis and electrophilic fragments enable rapid identification small molecules that selectively inhibit mutant protein. Using bromodomain-containing protein BRD4 as an example, employed structure-based approach...

10.1021/acschembio.3c00437 article EN cc-by ACS Chemical Biology 2023-10-24
Coming Soon ...